Download DNB 2019 June MICROBIOLOGY MICROBIOLOGY PAPER 4 Question Paper

Download Diplomate in National Board (DNB) 2019 June MICROBIOLOGY MICROBIOLOGY PAPER 4 Previous Question Papers

FINAL EXAM NATIONAL BOARD OF EXAMINATIONS
JUNE 2019
MICROBIOLOGY
PAPER-IV
Time: 3 hours MICRO/J/19/18/IV
Max. Marksz100
Important Instructions:
Attempt all questions in order.
Each question carries 10 marks.
Read the question carefully and answer to the point neatly and legib/y.
Do not leave any blank pages between two answers.
Indicate the question number correctly for the answer in the margin space.
Answer all the parts of a single question together.
Start the answer to a question on a fresh page or leave adequate space between two answers.
Draw table/diagrams/f/owcharts wherever appropriate.
Write short notes on:
1 .
10.
POSSESSION/USE OF CELL PHONES 0R AN Y S UCH ELECTRONIC GADGETS IS NOTPERMITTED INSIDE THE EXAMINA TION HALL.
a) Define multiple drug resistant (MDR) bacteria. 3+7
b) Role of active surveillance culture in prevention of hospital
acquired infections caused by MDR pathogens.
a) Enumerate the non-antibiotic alternatives to treat bacterial 4+6
infections.
b) Current status of bacteriophage therapy in management of
bacterial infections.
a) Whole genome sequencing. 3+2+3+2
b) RIBA.
0) Tuberculosis vaccines.
d) Inhaled antibiotics for Gram negative respiratory infections.
Define outbreak, epidemic and pandemic. Give an outline of the role 3+7
of a clinical microbiologist in management of an infectious disease
outbreak.
a) Definetaxonomy. 3+7
b) Advantages and disadvantages of molecular taxonomy.
Define reverse vaccinology. Give an outline of reverse vaccinology 3+7
technique with example.
a) Define pre-emptive, empiric and prophylactic antibiotic therapy. 3+7
b) Principles of prophylactic antibiotic therapy in prevention of
surgical site infections.
a) Enumerate the molecular epidemiological typing methods for 4+6
bacteria.
b) Parameters to evaluate efficacy of a typing method.
CRISPR-Cas system and enlist the applications of the CRISPR-Cas 5+5
technology in biomedical science.
a) Enumerate the uses of animal models in infectious disease 4+6
research.
b) Invertebrate models currently used in infectious disease research.
************